• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-(2-氯乙基)-3-环己基-1-亚硝基脲与L1210细胞核蛋白的结合

Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins.

作者信息

Woolley P V, Dion R L, Kohn K W, Bono V H

出版信息

Cancer Res. 1976 Apr;36(4):1470-4.

PMID:4221
Abstract

The binding of 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea (CCNU) to the proteins of the L1210 cell nucleus has been studied using both [cyclohexyl-14C]CCNU and [chloroethyl-14C]CCNU. Most of the bound [cyclohexyl-14C] moiety of CCNU was found to exist in a form that was stable in acid solution but labile and dialyzable in alkaline solution. A small amount of the cyclohexyl moiety was bound to histones in a stable, nondialyzable form. The drug/protein ratio for the H1 histone was about 0.01 to 0.02 mole/mole. No binding of the cyclohexyl group to acidic proteins or of the chloroethyl group to either histones or acidic proteins was observed. Thus, the interaction of CCNU with the proteins of the cell nucleus can be defined in terms of the modification of histones by the cyclohexyl moiety.

摘要

使用[环己基-¹⁴C]洛莫司汀(CCNU)和[氯乙基-¹⁴C]CCNU研究了1-(2-氯乙基)-3-(环己基)-1-亚硝基脲(CCNU)与L1210细胞核蛋白质的结合。发现CCNU大部分结合的[环己基-¹⁴C]部分以在酸性溶液中稳定但在碱性溶液中不稳定且可透析的形式存在。少量环己基部分以稳定的、不可透析的形式与组蛋白结合。H1组蛋白的药物/蛋白质比率约为0.01至0.02摩尔/摩尔。未观察到环己基与酸性蛋白质结合,也未观察到氯乙基与组蛋白或酸性蛋白质结合。因此,CCNU与细胞核蛋白质的相互作用可以通过环己基部分对组蛋白的修饰来定义。

相似文献

1
Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins.1-(2-氯乙基)-3-环己基-1-亚硝基脲与L1210细胞核蛋白的结合
Cancer Res. 1976 Apr;36(4):1470-4.
2
The binding of 14C labelled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) to macromolecules of sensitive and resistant tumours.14C标记的1-(2-氯乙基)-3-环己基-1-亚硝基脲(CCNU)与敏感和耐药肿瘤大分子的结合
Br J Cancer. 1974 Nov;30(5):477-80. doi: 10.1038/bjc.1974.224.
3
Active site specific inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.在抗癌药物1-(2-氯乙基)-3-环己基-1-亚硝基脲降解过程中形成的环己基异氰酸酯对胰凝乳蛋白酶的活性位点特异性失活作用。
Biochemistry. 1977 Apr 19;16(8):1584-9. doi: 10.1021/bi00627a009.
4
DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.暴露于1-(2-氯乙基)-3-环己基-1-亚硝基脲的L1210细胞中的DNA损伤与修复
Cancer Res. 1977 Jul;37(7 Pt 1):2262-6.
5
Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.L5178Y淋巴母细胞在体外摄取亚硝基脲的机制。
Cancer Res. 1977 Apr;37(4):1022-7.
6
Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.1,3-双(2-氯乙基)-1-亚硝基脲(卡莫司汀,BCNU)与1-(2-氯乙基)-3-环己基-1-亚硝基脲(洛莫司汀,CCNU)在大鼠器官和脑肿瘤中的摄取、分布及组织/血浆分配的药代动力学关系
Cancer Chemother Pharmacol. 1978;1(4):233-42. doi: 10.1007/BF00257156.
7
Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.两性霉素B与1-(2-氯乙基)-3-环己基-1-亚硝基脲联合使用对小鼠室管膜母细胞瘤RNA合成的抑制作用
Cancer Res. 1980 Mar;40(3):939-42.
8
DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.用氮芥、1,3-双(2-氯乙基)-1-亚硝基脲及其他亚硝基脲处理的小鼠白血病L1210细胞中的DNA损伤与修复
Cancer Res. 1977 Jul;37(7 Pt 1):2114-22.
9
Binding of chlorozotocin and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to chromatin and nucleosomal fractions of HeLa cells.氯脲霉素和1-(2-氯乙基)-3-环己基-1-亚硝基脲与HeLa细胞染色质及核小体组分的结合
Cancer Res. 1978 Oct;38(10):3371-8.
10
Comparison of biochemical and biological effects of four nitrosoureas with differing carbamoylating activities.四种具有不同氨甲酰化活性的亚硝基脲的生化和生物学效应比较。
Cancer Res. 1978 Aug;38(8):2363-6.

引用本文的文献

1
Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells.Nrf2的过表达可减轻卡莫司汀诱导的U87MG人胶质瘤细胞的细胞毒性。
BMC Cancer. 2015 Mar 13;15:118. doi: 10.1186/s12885-015-1134-z.
2
Interstitial chemotherapy for malignant glioma: Future prospects in the era of multimodal therapy.恶性胶质瘤的间质化疗:多模态治疗时代的未来前景。
Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S78-84. doi: 10.4103/2152-7806.151345. eCollection 2015.
3
Effective elimination of cancer stem cells by a novel drug combination strategy.
新型药物联合策略有效消除癌症干细胞。
Stem Cells. 2013 Jan;31(1):23-34. doi: 10.1002/stem.1273.
4
Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.缓释植入用盐酸尼莫司汀(丽珠环明)治疗恶性脑胶质瘤。
Ther Clin Risk Manag. 2007 Oct;3(5):707-15.